Tag Archives: Zantac

More generic Zantac recalled as NDMA contamination concerns build

The recalls of generic Zantac tainted by a suspected carcinogen continue to roll in. Two more companies have announced recalls of 18 lots of ranitidine heartburn meds in 150 mg and 300 mg doses.  Indianapolis-based Denton Pharma, which does business as Northwind Pharmaceuticals, voluntarily recalled 10 lots of ranitidine manufactured by Glenmark because they were… Read More »

Zantac and some OTC meds found to contain suspected carcinogen first discovered in blood pressure drugs

The saga of potentially dangerous impurities in the U.S. drug supply continues. A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Sanofi’s Zantac and some over-the-counter heartburn drugs.  At this point, the FDA says that while N-nitrosodimethylamine (NDMA) has been discovered in these ranitidine medicines like… Read More »